Aruna Biomedical Taps RiversEdge BioVentures for Strategic Advisory Services | GenomeWeb

NEW YORK (GenomeWeb News) - Stem cell research tools company Aruna Biomedical said yesterday that it has hired recently formed life sciences advisory and investment services firm RiversEdge BioVentures to evaluate strategic alternatives for Aruna.

RiversEdge will evaluate potential fundraising opportunities for Aruna, expansion of its strategic partnerships, and potential combinations with strategic and financial investors, among other services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.